EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammation at the Maternal–Fetal Interface: Mechanisms Linking Maternal–Fetal Immunity to Preeclampsia and Fetal Growth Restriction

Jezid Miranda, Natalia Maestre, Mariana Devia iD, Roberto Zapata iD, Margarita M Ochoa-Díaz iD, Walter Annicchiarico iD

International Journal of Molecular Sciences · 29.04.2026 · 27 (9) · 3954

DOI: 10.3390/ijms27093954 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.04.2026. Verfasst von Jezid Miranda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, University of Cartagena, Zaragocilla Carrera 50 #24-63, Cartagena de Indias 130014, Col…. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Pre-Eclampsia, Inflammation, Placenta. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation is a physiological and tightly regulated component of normal pregnancy, contributing to implantation, placental development, and the initiation of parturition. The placenta functions as an active immunological hub, coordinating innate and adaptive immune responses to maintain tolerance while protecting against infection. Preeclampsia and fetal growth restriction (FGR) are major causes of maternal and perinatal morbidity worldwide and represent central manifestations of placental disease. Increasing evidence indicates that these conditions share key pathophysiological mechanisms, including placental dysfunction and maladaptive maternal immune responses. When immune regulation at the maternal–fetal interface becomes disrupted, inflammatory pathways contribute to impaired placental development and vascular maladaptation. In this context, excessive immune activation—driven by inflammasome signaling, Th1/Th17 polarization, and altered natural killer and macrophage function—can compromise placental perfusion, promote antiangiogenic imbalance, and lead to systemic endothelial dysfunction. This review, therefore, focuses on how immune dysregulation contributes to placental dysfunction in preeclampsia and FGR, synthesizing current knowledge of the maternal–fetal immune interface and exploring therapeutic strategies that link pathogenic mechanisms to targeted interventions. A deeper understanding of placental immunology and inflammatory signaling is essential to develop precision therapies. Established therapies, including low-dose aspirin, low-molecular-weight heparin, and antenatal corticosteroids, aim to mitigate inflammation and optimize fetal outcomes, while adjunctive strategies target oxidative stress, nutritional deficits, and the maternal microbiome. Emerging approaches such as cytokine-targeted biologics, inflammasome inhibitors, and mesenchymal stem cell therapies show promise but require rigorous safety and efficacy evaluation. Future research should prioritize biomarker validation, pathway-specific interventions, and equitable implementation to reduce inflammation-driven pregnancy complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Growth RetardationPre-EclampsiaInflammationPlacentaMaternal-Fetal ExchangeHumansFemalePregnancyAnimals

Stichwörter der Autor:innen

fetal growth restrictioninflammationmaternal–fetal interfaceplacentapreeclampsiapregnancy complicationstargeted therapy

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, University of Cartagena, Zaragocilla Carrera 50 #24-63, Cartagena de Indias 130014, Colombia.
  • Department of Obstetrics and Gynecology, Centro Hospitalario Serena del Mar, Cartagena de Indias 130008, Colombia.
  • Department of Obstetrics and Gynecology, University of Sinu, Cartagena de Indias 130015, Colombia.
  • Department of Obstetrics and Gynecology, Clinica General Del Norte, Barranquilla 080002, Colombia.
  • School of Medicine, Grupo de Investigación Básicas y Clínicas Facultad de Ciencias de Salud (GIBACUS), University of Sinu, Cartagena de Indias 130015, Colombia.

ORCID-Profile: Mariana Devia, Roberto Zapata, Margarita M Ochoa-Díaz, Walter Annicchiarico

Zitieren

APA

Miranda, J., Maestre, N., Devia, M., Zapata, R., Ochoa-Díaz, M. M., & Annicchiarico, W. (2026). Inflammation at the Maternal–Fetal Interface: Mechanisms Linking Maternal–Fetal Immunity to Preeclampsia and Fetal Growth Restriction. International Journal of Molecular Sciences, 27(9), 3954. https://doi.org/10.3390/ijms27093954

Vancouver

Miranda J, Maestre N, Devia M, Zapata R, Ochoa-Díaz MM, Annicchiarico W. Inflammation at the Maternal–Fetal Interface: Mechanisms Linking Maternal–Fetal Immunity to Preeclampsia and Fetal Growth Restriction. International Journal of Molecular Sciences. 2026;27(9):3954. doi:10.3390/ijms27093954

BibTeX
@article{Miranda2026,
  author = {Miranda, Jezid and Maestre, Natalia and Devia, Mariana and Zapata, Roberto and Ochoa-Díaz, Margarita M and Annicchiarico, Walter},
  title = {Inflammation at the Maternal–Fetal Interface: Mechanisms Linking Maternal–Fetal Immunity to Preeclampsia and Fetal Growth Restriction},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {3954},
  doi = {10.3390/ijms27093954}
}
Kostenlos starten →